SCHEMBL28120647

SCHEMBL28120647

CCS(=O)(=O)Nc1ccc(-c2cccc3cnc(Nc4cccc(N5CCN(C(C)=O)CC5)c4)nc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.60
▸ JAK2 O60674 4/20 0.53
▸ BRD4 O60885 3/20 0.53
▸ CDK2 P24941 8/20 0.49
▸ CCNT1 O60563 7/20 0.49
▸ CCNA2 P20248 7/20 0.49
▸ CDK9 P50750 7/20 0.49
▸ CDK1 P06493 4/20 0.49
▸ CCNB1 P14635 4/20 0.49
▸ FLT3 P36888 2/20 0.49
▸ JAK3 P52333 2/20 0.49
▸ FGFR2 P21802 1/20 0.49
▸ JAK1 P23458 1/20 0.49
▸ CDK7 P50613 3/20 0.48
▸ CCNH P51946 3/20 0.48
▸ CCNA1 P78396 2/20 0.47
▸ PTK2 Q05397 1/20 0.46
▸ SYK P43405 1/20 0.46
▸ CDK4 P11802 1/20 0.46
▸ CCND1 P24385 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18376249 0.92 EGFR (0.61) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL29205109 0.89 EGFR (0.58) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL18377056 0.89 EGFR (0.60) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL18376844 0.88 EGFR (0.65) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL18376829 0.87 EGFR (0.60) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL29368834 0.87 EGFR (0.62) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL18376840 0.87 EGFR (0.62) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL18376831 0.87 EGFR (0.56) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL18376835 0.86 EGFR (0.58) EGFRJAK2BRD4CDK2CCNT1
SCHEMBL18377053 0.86 EGFR (0.59) EGFRJAK2BRD4CDK2CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN claimed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN disclosed
Send feedback